Lam Research (NASDAQ:LRCX) Shares Down 1.3% – Should You Sell?

Lam Research Corporation (NASDAQ:LRCX) shares were down 1.3% during trading on Wednesday. The company traded as low as $321.11 and last traded at $329.51. Approximately 6,238,499 shares traded hands during mid-day trading, a decline of 42% from the average session volume of 10,727,210 shares. The stock had previously closed at $333.89.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: AI and semiconductor demand support the outlook. Zacks identified Lam Research, alongside NVIDIA, Applied Materials and TSMC, as companies with consistent earnings performance and durable growth exposure to artificial intelligence. Demand for advanced semiconductor manufacturing equipment, advanced packaging and high-bandwidth memory (HBM) remains a key growth driver. 4 Top Chip Stocks With Dependable Earnings to Ride the AI Boom
• Positive Sentiment: Analysts remain constructive on LRCX. Recent analyst and industry commentary highlights Lam Research as a beneficiary of the prospering semiconductor industry, with AI-driven investment expected to sustain equipment demand. Morgan Stanley also reportedly raised its price target for Lam Research, adding to the positive sentiment. TSMC Stock Hits Record High, Morgan Stanley Raises Lam Research Price Target
• Neutral Sentiment: Lam is growing faster than KLA, but investors are paying a premium. A comparison with KLA suggests LRCX has stronger current growth, while its valuation relative to trailing free cash flow is higher. The debate is whether Lam’s faster expansion justifies that premium. Lam Research vs. KLA: Is Faster Growth Worth Paying More for Cash Flow?
• Negative Sentiment: Premium valuation may be weighing on the stock. Zacks noted that LRCX’s high valuation is supported by rising earnings, improving margins and AI exposure, but the elevated price leaves less room for disappointment. The company’s latest reported quarter exceeded EPS and revenue expectations, with revenue up 30% year over year, although investors may already have priced in much of that strength. Should You Invest in Lam Research Stock Despite Its Premium Valuation?
• Neutral Sentiment: One submitted item refers to an abdominoplasty clinical trial while attributing it to Lam Research. This appears unrelated to the semiconductor-equipment company and does not provide a credible investment catalyst. New Abdominoplasty Trial Signals Steady Demand in Procedure-Driven Healthcare

Wall Street Analyst Weigh In

A number of brokerages have issued reports on LRCX. UBS Group cut their target price on Lam Research from $435.00 to $425.00 and set a “buy” rating on the stock in a research report on Tuesday, September 1st. Oppenheimer reissued an “outperform” rating and set a $400.00 price target (up from $330.00) on shares of Lam Research in a research report on Monday, June 15th. Stifel Nicolaus lifted their price target on shares of Lam Research from $325.00 to $425.00 and gave the stock a “buy” rating in a research note on Friday, July 10th. Rothschild & Co Redburn upped their price target on shares of Lam Research from $305.00 to $420.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. Finally, Berenberg Bank set a $420.00 price objective on shares of Lam Research in a research note on Wednesday, September 9th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $364.59.

Lam Research Trading Down 1.3%

The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. The company has a market cap of $412.36 billion, a price-to-earnings ratio of 57.21, a price-to-earnings-growth ratio of 1.37 and a beta of 1.85. The firm has a 50-day moving average price of $308.48 and a 200 day moving average price of $304.45.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The business had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. During the same period in the prior year, the company posted $1.33 EPS. The business’s revenue was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, sell-side analysts forecast that Lam Research Corporation will post 9.32 EPS for the current year.

Lam Research Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Wednesday, September 23rd. This is an increase from Lam Research’s previous quarterly dividend of $0.26. Lam Research’s payout ratio is 22.92%.

Insider Activity

In other news, Director Abhijit Talwalkar sold 18,282 shares of Lam Research stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the transaction, the director directly owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. The trade was a 17.34% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 5,000 shares of the business’s stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the sale, the insider directly owned 42,462 shares of the company’s stock, valued at approximately $12,843,056.52. This represents a 10.53% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 32,839 shares of company stock valued at $10,644,740. Company insiders own 0.31% of the company’s stock.

Institutional Trading of Lam Research

Institutional investors and hedge funds have recently made changes to their positions in the stock. Polaris Financial Partners bought a new position in shares of Lam Research in the third quarter worth about $4,814,000. Bank of America Corp DE grew its holdings in Lam Research by 5.5% in the 2nd quarter. Bank of America Corp DE now owns 11,244,147 shares of the semiconductor company’s stock valued at $4,872,426,000 after buying an additional 584,489 shares during the last quarter. Rokos Capital Management LLP increased its position in Lam Research by 42.0% in the 1st quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company’s stock worth $55,532,000 after buying an additional 76,840 shares during the period. Aware Super Pty Ltd as trustee of Aware Super acquired a new position in shares of Lam Research during the first quarter worth approximately $59,973,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Lam Research in the first quarter valued at approximately $26,489,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

About Lam Research

Lam Research Corporation is a semiconductor equipment company that designs, manufactures, and services systems used in the fabrication of integrated circuits and other electronic devices. Its equipment supports key steps in the wafer manufacturing process, helping semiconductor producers create increasingly small and complex features on silicon wafers.

The company’s portfolio includes systems for etch, deposition, wafer cleaning, surface preparation, and related manufacturing processes.